Intrua Financial’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $206K | Sell |
508
-71
| -12% | -$28.8K | 0.03% | 359 |
|
|
2025
Q1 | $288K | Buy |
579
+60
| +12% | +$29.9K | 0.04% | 287 |
|
|
2024
Q4 | $270K | Sell |
519
-74
| -12% | -$38.5K | 0.04% | 289 |
|
|
2024
Q3 | $367K | Buy |
593
+6
| +1% | +$3.71K | 0.05% | 275 |
|
|
2024
Q2 | $325K | Buy |
587
+55
| +10% | +$30.4K | 0.05% | 292 |
|
|
2024
Q1 | $309K | Buy |
532
+26
| +5% | +$15.1K | 0.04% | 314 |
|
|
2023
Q4 | $269K | Sell |
506
-11
| -2% | -$5.84K | 0.04% | 333 |
|
|
2023
Q3 | $262K | Buy |
517
+4
| +0.8% | +$2.03K | 0.04% | 289 |
|
|
2023
Q2 | $268K | Sell |
513
-13
| -2% | -$6.78K | 0.05% | 292 |
|
|
2023
Q1 | $276K | Buy |
526
+32
| +6% | +$16.8K | 0.06% | 267 |
|
|
2022
Q4 | $288K | Buy |
494
+1
| +0.2% | +$584 | 0.07% | 257 |
|
|
2022
Q3 | $250K | Sell |
493
-816
| -62% | -$414K | 0.07% | 257 |
|
|
2022
Q2 | $711K | Sell |
1,309
-29
| -2% | -$15.8K | 0.15% | 150 |
|
|
2022
Q1 | $790K | Buy |
1,338
+40
| +3% | +$23.6K | 0.14% | 152 |
|
|
2021
Q4 | $866K | Buy |
1,298
+9
| +0.7% | +$6.01K | 0.15% | 136 |
|
|
2021
Q3 | $789K | Buy |
1,289
+2
| +0.2% | +$1.22K | 0.15% | 155 |
|
|
2021
Q2 | $691K | Buy |
1,287
+25
| +2% | +$13.4K | 0.17% | 132 |
|
|
2021
Q1 | $619K | Buy |
1,262
+33
| +3% | +$16.2K | 0.16% | 137 |
|
|
2020
Q4 | $572K | Sell |
1,229
-559
| -31% | -$260K | 0.26% | 80 |
|
|
2020
Q3 | $874K | Buy |
1,788
+48
| +3% | +$23.5K | 0.43% | 50 |
|
|
2020
Q2 | $725K | Buy |
+1,740
| New | +$725K | 0.28% | 79 |
|